Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
Papanin PutsathitStacey HongNarelle GeorgeChristine HemphillPeter G HuntingtonTony M KormanDespina KotsanasMonica LahraRodney McDougallAndrew McGlincheyCasey V MooreGraeme R NimmoLouise PrendergastJennifer RobsonLynette WaringMichael C WehrhahnGerhard F WeldhagenRichard M WilsonThomas V RileyDaniel R KnightPublished in: The Journal of antimicrobial chemotherapy (2021)
The majority of C. difficile isolated in Australia did not show reduced susceptibility to antimicrobials recommended for treatment of CDI (vancomycin, metronidazole and fidaxomicin). Resistance to carbapenems and fluoroquinolones was low and MDR was uncommon; however, clindamycin resistance was frequent. One fluoroquinolone-resistant ribotype 027 strain was detected.